Healthcare Services

Global Fatty Liver Treatment Industry Trends and Market Growth Forecast for 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Fatty Liver Treatment Market By The End Of 2030?

The fatty liver treatment market has shown robust growth over recent years. It is anticipated to increase from $25.05 billion in 2025 to $26.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This historical expansion can be linked to several factors, including a rise in obesity rates, the growing prevalence of diabetes, enhancements in liver diagnostic tools, increased understanding of liver health, and the establishment of more hepatology clinics.

The fatty liver treatment market is projected to experience substantial expansion in the coming years. This market is forecast to reach a valuation of $35.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. The anticipated growth during this period stems from factors such as the creation of innovative NAFLD medications, the rising adoption of non-invasive diagnostic methods, the expansion of preventive healthcare measures, the broadening of tele-hepatology services, and increased funding for liver disease research. Key trends projected for the forecast period encompass the increasing occurrence of non-alcoholic fatty liver disease, a heightened emphasis on lifestyle-centric treatment strategies, the expanding application of targeted drug therapies, wider implementation of early liver disease screening, and the incorporation of digital health solutions for monitoring the condition.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

What Primary Drivers Are Shaping The Development Of The Fatty Liver Treatment Market?

The rising intake of alcohol is anticipated to drive the expansion of the fatty liver treatment market moving forward. Alcohol consumption refers to the intake of beverages containing alcohol, which is a psychoactive substance with depressant effects on the central nervous system. This consumption can worsen fatty liver disease and lead to more severe liver conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For instance, in November 2025, the OECD, a Paris-based intergovernmental organization, stated that in 2023, the annual per capita alcohol consumption across its member countries averaged 8.5 liters of pure alcohol. Therefore, the increase in alcohol consumption is propelling the growth of the fatty liver treatment market.

Which Segment Classifications Shape The Fatty Liver Treatment Market?

The fatty liver treatment market covered in this report is segmented –

1) By Treatment Type: Anti-Viral Drugs, Chemotherapy Drugs, Targeted Therapy, Anti-Fibrotic Drugs

2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases

3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs), Nucleos(t)ide Analogs

2) By Chemotherapy Drugs: Conventional Chemotherapy Agents, Novel Chemotherapeutics Under Investigation

3) By Targeted Therapy: Small Molecule Inhibitors, Monoclonal Antibodies

4) By Anti-Fibrotic Drugs: PPAR Agonists, FXR Agonists, GLP-1 Receptor Agonists, SGLT2 Inhibitors, Other Insulin Sensitizers

How Are Trends Impacting The Fatty Liver Treatment Market?

Leading companies within the fatty liver treatment market are concentrating on creating innovative solutions, including next-generation metabolic-modulating biologics, to satisfy the growing need for effective therapies that address the fundamental mechanisms of NAFLD and NASH. These biologic treatments engage with critical metabolic and inflammatory pathways, presenting a more precise and disease-modifying strategy when contrasted with conventional lifestyle interventions, which offer constrained therapeutic effects for advanced stages of the condition. As an illustration, in March 2023, Akero Therapeutics, a US-based biotechnology company, announced favorable Phase II results for efruxifermin, intended for the treatment of non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This particular substance is a differentiated Fc-FGF21 fusion protein designed to emulate the biological activity of fibroblast growth factor 21 (FGF21), a molecule responsible for regulating various metabolic pathways and cellular processes.

Which Companies Are Expanding Their Footprint In The Fatty Liver Treatment Market?

Major companies operating in the fatty liver treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, Gilead Sciences Inc., Novo Nordisk A/S, Intercept Pharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Genfit, Conatus Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Cardax Inc., Eisai Co. Ltd., Alnylam Pharmaceuticals Inc.

Read the full fatty liver treatment market report here:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

How Does The Fatty Liver Treatment Market Perform Across Major Global Regions?

North America was the largest region in the fatty liver treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Fatty Liver Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12581&type=smp

Browse Through More Reports Similar to the Global Fatty Liver Treatment Market 2026, By The Business Research Company

Liver Diseases Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Metastases Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-metastases-treatment-global-market-report

Non Alcoholic Steatohepatitis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795